Viberzi: Uses, Dosage, Demographic, Side Effects, Interactions & Generic Options Viberzi is a prescription drug that is approved by the US Food and Drug Administration (FDA) for the treatment of irritable bowel syndrome with diarrhea (IBS-D). This medication is also known by its generic name, eluxadoline, and it works by reducing bowel contractions that cause diarrhea and by decreasing sensitivity to pain in the gut. In this article, we’ll discuss all the important aspects of Viberzi, including its uses, dosage, demographic, side effects, interactions, and generic options. Usage of Viberzi: Viberzi is primarily used to treat IBS-D, a common but disruptive condition that affects the functioning of the digestive system. With IBS-D, patients typically experience abdominal pain, discomfort, bloating, and frequent diarrhea, often alternating with constipation. While the exact cause of IBS is not completely understood, it is thought that factors such as stress, diet, and genetics can all play a role in the development of this condition. Viberzi is designed to alleviate the symptoms of IBS-D by slowing down the movement of food through the gut, which reduces diarrhea, and by reducing pain and discomfort in the gut. This medication can be used in adult patients who are over 18 years old. Dosage and Administration: The dosage of Viberzi is determined by the doctor and is usually based on the severity of the patient’s IBS-D symptoms, as well as other factors such as age, sex, and overall health. The standard dosage of Viberzi is 100 mg twice per day, with food. It is important to take Viberzi exactly as prescribed by the doctor, and not to take more or less than the recommended dose. Patients should also avoid cutting, crushing, or chewing the tablets, and should swallow them whole. Demographics: Viberzi is approved for use in adult patients over the age of 18 who are diagnosed with IBS-D. This medication is not recommended for use in patients who have a history of biliary obstruction, pancreatitis, severe liver impairment, or have had their gallbladder removed. Women who are pregnant or breastfeeding should also consult their doctor before taking Viberzi. Side Effects: Like all medications, Viberzi can cause some side effects, although not all patients experience them. Common side effects of Viberzi include constipation, nausea, abdominal pain, and vomiting. In rare cases, more serious side effects such as pancreatitis, allergic reactions, liver injury, and severe constipation can occur. Interactions: Viberzi can interact with other medications, including opioids, antifungal drugs, and antibiotics. It is important to inform the doctor about all other medications and supplements that the patient is taking before starting Viberzi. Generic Options: Viberzi is the brand name of eluxadoline, and it is the only drug currently approved by the FDA for the treatment of IBS-D. However, there are other medications that can be used to treat IBS, such as antispasmodics, laxatives, and antidepressants, although they may not be as effective as Viberzi in reducing diarrhea and abdominal pain. Conclusion: Viberzi is a prescription drug that is approved for the treatment of IBS-D. It is a medication that reduces bowel contractions that cause diarrhea and decreases sensitivity to pain in the gut. Viberzi is usually prescribed in a standard dosage of 100mg twice per day, with food. Although Viberzi is generally safe and well-tolerated, it can cause some side effects and interactions with other medications. Patients who are considering taking Viberzi should consult their doctor and discuss the risks and benefits of this medication.